The Argus II, a “bionic eye”, is intended to provide electrical stimulation of the retina to elicit visual perception in blind subjects with severe to profound retinitis pigmentosa, according to the company.
The implant is an epiretinal prosthesis surgically implanted in and on the eye that includes an antenna, an electronics case and an electrode array.
There have been only 30 people worldwide to test the device.
Related Articles on Ophthalmology:
Retina Group of Washington Opens VA Office in Vienna
TX’s William Beaumont Army Medical Center Opens Eye Surgery Clinic
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
